FDA Import Refusal 1FX-6228321-2/20002/1 — BNC Global
The FDA refused shipment 1FX-6228321-2/20002/1 from BNC Global (South Korea) on June 3, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 237,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- June 3, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 237,75